- Thomson Reuters StreetEvents via Yahoo FinanceAug 06 22:24 PM
Mallinckrodt plc - President, CEO & Director * Steven J. Romano Mallinckrodt plc - Executive VP & Chief Scientific Officer... Division - MD * Anthony Charles Petrone Jefferies ...
- Market Watch4 days ago
The Daily Biotech Pulse: Regeneron's Bad Cholesterol Drug Aces Late-Stage Trial, Oncolytics OfferingMSN News5 hours ago
Pain Management Market Developments Eyeing Remarkable Growth Due to Technological Advancements, Drugs, Devices and Trends - Latest Clinical...Market Watch2 days ago
- Thomson Reuters StreetEvents via Yahoo FinanceAug 16 9:11 AM
I would like to point out that our bronchiolitis treatment is expected to be administered 4 times per day for 40 minutes and with up to 5 days maximum at 150 parts per million nitric oxide.